Shire US Holdings, Inc. | Takeda Pharmaceutical | Pennsylvania | state | 2014 | $914,646 | | tax credit/rebate |
Amgen, Inc. | Amgen | Pennsylvania | state | 2014 | $608,537 | | tax credit/rebate |
CSL Behring, LLC | CSL Limited | Pennsylvania | state | 2014 | $574,748 | | tax credit/rebate |
Auxilium Pharmacueticals, Inc. | Endo International | Pennsylvania | state | 2014 | $426,723 | | tax credit/rebate |
Sanofi US Services, Inc. | Sanofi | Pennsylvania | state | 2014 | $314,989 | | tax credit/rebate |
Novo Nordisk, Inc. | Novo Holdings A/S | Pennsylvania | state | 2014 | $178,257 | | tax credit/rebate |
Callidus Biopharma, Inc. | Amicus Therapeutics | Pennsylvania | state | 2014 | $98,490 | | tax credit/rebate |
Vitae Pharmaceuticals, Inc. (f/k/a Concurrent Pharmaceuticals, Inc.) | AbbVie | Pennsylvania | state | 2014 | $83,843 | | tax credit/rebate |
Immunex Corporation | Amgen | Pennsylvania | state | 2014 | $74,054 | | tax credit/rebate |
Jazz Pharmaceuticals, Inc. | Jazz Pharmaceuticals | Pennsylvania | state | 2014 | $34,743 | | tax credit/rebate |
Aclaris Therapeutics, Inc. | Aclaris Therapeutics | Pennsylvania | state | 2014 | $20,248 | | tax credit/rebate |
Boehringer Ingelheim Pharmaceuticals, Inc. | Boehringer Ingelheim | Pennsylvania | state | 2014 | $4,825 | | tax credit/rebate |
Amgen USA, Inc. | Amgen | Pennsylvania | state | 2014 | $3,556 | | tax credit/rebate |
Immunex Rhode Island Corp. | Amgen | Rhode Island | state | 2015 | $56,783 | | tax credit/rebate |
NOVO NORDISK INC | Novo Holdings A/S | Washington | state | 2014 | $273,088 | | tax credit/rebate |
GILEAD SCIENCES INC | Gilead Sciences | Washington | state | 2014 | $403,872 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2014 | $13,522 | | tax credit/rebate |
IMMUNE DESIGN CORP | Merck | Washington | state | 2014 | $22,572 | | tax credit/rebate |
EMERGENT PRODUCT DEVELOPMENT SEATTLE LLC | Emergent BioSolutions | Washington | state | 2014 | $83,367 | | tax credit/rebate |
NOVO NORDISK INC | Novo Holdings A/S | Washington | state | 2014 | $48,418 | | tax credit/rebate |
OMEROS CORP | Omeros Corp. | Washington | state | 2014 | $398,897 | | tax credit/rebate |
GILEAD SCIENCES INC | Gilead Sciences | Washington | state | 2014 | $41,681 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2014 | $185,655 | | tax credit/rebate |
ONCOTHYREON INC | Seattle Genetics Inc. | Washington | state | 2014 | $19,669 | | tax credit/rebate |
IMMUNE DESIGN CORP | Merck | Washington | state | 2014 | $10,326 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2014 | $102,925 | | tax credit/rebate |
EMERGENT PRODUCT DEVELOPMENT SEATTLE LLC | Emergent BioSolutions | Washington | state | 2014 | $83,218 | | tax credit/rebate |
SANOFI AVENTIS US LLC | Sanofi | Washington | state | 2014 | $70,422 | | tax credit/rebate |
Astellas US LLC and its subsidiaries and related entities | Astellas Pharma | Illinois | state | 2014 | $3,398,678 | | tax credit/rebate |
Astellas US LLC and its subsidiaries and related entities | Astellas Pharma | Illinois | state | 2013 | $1,383,958 | | tax credit/rebate |
Emergent BioSolutions Inc. | Emergent BioSolutions | Maryland | state | 2015 | $2,000,000 | | grant/loan hybrid program |
MedImmune LLC | AstraZeneca | Maryland | state | 2015 | $1,500,000 | | grant/loan hybrid program |
Emergent Biosolutions | Emergent BioSolutions | Michigan | state | 2012 | $2,821,980 | | tax increment financing |
Emergent Biosolutions | Emergent BioSolutions | Michigan | state | 2012 | $1,796,389 | | tax increment financing |
Perrigo Company | Perrigo | Michigan | state | 2013 | $21,463,000 | | property tax abatement |
Perrigo Company | Perrigo | Michigan | state | 2013 | $14,315,000 | | tax credit/rebate |
Perrigo Company | Perrigo | Michigan | state | 2013 | $2,300,000 | | tax credit/rebate |
Perrigo Company | Perrigo | Michigan | state | 2013 | $2,500,000 | | tax credit/rebate |
Boehringer Ingelheim Vetmedica Inc. | Eli Lilly | Iowa | state | 2015 | $516,584 | | tax credit/rebate |
Dr. Reddys Laboratories Louisiana LLC | Dr. Reddy's Laboratories | Louisiana | state | 2015 | $749,365 | | property tax abatement |
Dr. Reddys Laboratories Louisiana LLC | Dr. Reddy's Laboratories | Louisiana | state | 2015 | $617,069 | | property tax abatement |
Moderna Therapeutics | Moderna Inc. | Massachusetts | state | 2014 | $450,000 | | tax credit/rebate |
Shire Human Genetic Therapies | Takeda Pharmaceutical | Massachusetts | state | 2014 | $597,076 | | tax credit/rebate |
Synageva BioPharma | AstraZeneca | Massachusetts | state | 2014 | $1,021,550 | | tax credit/rebate |
PAREXEL International | Parexel International | Massachusetts | state | 2014 | $1,062,412 | | tax credit/rebate |
Foundation Medicine | Roche | Massachusetts | state | 2014 | $1,225,860 | | tax credit/rebate |
Biogen Idec | Biogen | Massachusetts | state | 2014 | $6,250,000 | | tax credit/rebate |
Moderna Therapeutics | Moderna Inc. | Massachusetts | state | 2014 | $300,000 | | tax credit/rebate |
Alnylam Pharmaceuticals | Alnylam Pharmaceuticals | Massachusetts | state | 2014 | $612,930 | | tax credit/rebate |
Merrimack Pharmaceuticals | Merrimack Pharmaceuticals | Massachusetts | state | 2014 | $633,361 | | tax credit/rebate |
Aegerion Pharmaceuticals | Amryt Pharma | Massachusetts | state | 2014 | $715,085 | | tax credit/rebate |
Alliance Pharma, Inc. | Alliance Pharma PLC | Pennsylvania | state | 2014 | $100,000 | | tax credit/rebate |
Alliance Pharma, Inc. | Alliance Pharma PLC | Pennsylvania | state | 2015 | $100,000 | | tax credit/rebate |
ALLERGAN INC | AbbVie | California | state | 2015 | $325,700 | | training reimbursement |
AMGEN INC | Amgen | California | state | 2015 | $198,301 | | training reimbursement |
GILEAD SCIENCES INC | Gilead Sciences | California | state | 2015 | $191,250 | | training reimbursement |
PHARMAFORCE INC | Daiichi Sankyo | Ohio | state | 2009 | | $6,000,000 | loan or bond financing |
ABBOTT LABORATORIES | Abbott Laboratories | Ohio | state | 2012 | | $1,500,000 | loan or bond financing |
GlaxoSmithKline, LLC (f/k/a SmithKline Beecham Corporation) | GlaxoSmithKline | Pennsylvania | state | 2015 | $2,269,398 | | tax credit/rebate |
Shire Holdings US, AG | Takeda Pharmaceutical | Pennsylvania | state | 2015 | $1,223,167 | | tax credit/rebate |
Endo Pharmaceuticals, Inc. | Endo International | Pennsylvania | state | 2015 | $1,170,852 | | tax credit/rebate |
Janssen Research & Development, LLC | Johnson & Johnson | Pennsylvania | state | 2015 | $539,632 | | tax credit/rebate |
Janssen Biotech, Inc. | Johnson & Johnson | Pennsylvania | state | 2015 | $417,304 | | tax credit/rebate |
Shire ViroPharma Incorporated | Takeda Pharmaceutical | Pennsylvania | state | 2015 | $312,596 | | tax credit/rebate |
Jazz Pharmaceuticals, Inc. | Jazz Pharmaceuticals | Pennsylvania | state | 2015 | $160,237 | | tax credit/rebate |
Shire Human Genetic Therapies, Inc. | Takeda Pharmaceutical | Pennsylvania | state | 2015 | $85,593 | | tax credit/rebate |
Vitae Pharmaceuticals, Inc. | AbbVie | Pennsylvania | state | 2015 | $80,382 | | tax credit/rebate |
Novira Therapeutics, Inc. | Johnson & Johnson | Pennsylvania | state | 2015 | $73,815 | | tax credit/rebate |
Auxilium Pharmaceuticals, Inc. | Endo International | Pennsylvania | state | 2015 | $66,990 | | tax credit/rebate |
NewLink Genetics Corporation | Lumos Pharma | Pennsylvania | state | 2015 | $57,669 | | tax credit/rebate |
Supelco, Inc. | Merck KGaA (EMD) | Pennsylvania | state | 2015 | $17,786 | | tax credit/rebate |
Aclaris Therapeutics, Inc. | Aclaris Therapeutics | Pennsylvania | state | 2015 | $12,925 | | tax credit/rebate |
Merck Sharpe & Dohme | Merck | Virginia | state | 2016 | $1,300,000 | | grant |
SANOFI-AVENTIS US LLC | Sanofi | Washington | state | 2015 | $70,422 | | tax credit/rebate |
OMEROS CORPORATION | Omeros Corp. | Washington | state | 2015 | $398,897 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2015 | $102,925 | | tax credit/rebate |
NOVO NORDISK INC | Novo Holdings A/S | Washington | state | 2015 | $48,418 | | tax credit/rebate |
GILEAD SCIENCES INC | Gilead Sciences | Washington | state | 2015 | $41,681 | | tax credit/rebate |
CASCADIAN THERAPEUTICS INC | Seattle Genetics Inc. | Washington | state | 2015 | $19,669 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2015 | $13,467 | | tax credit/rebate |
IMMUNE DESIGN CORP | Merck | Washington | state | 2015 | $10,326 | | tax credit/rebate |
Purdue Pharma Manufacturing L. P. | Purdue Pharma | North Carolina | state | 2016 | $225,000 | | grant |
Novo Nordisk Pharmaceutical Industries, Inc. | Novo Holdings A/S | North Carolina | state | 2015 | $21,149,000 | | grant |
Novozymes North America, Inc. | Novo Holdings A/S | North Carolina | state | 2016 | $200,000 | | grant |
Dr. Reddys Laboratories Louisiana LLC | Dr. Reddy's Laboratories | Louisiana | state | 2016 | $26,694 | | property tax abatement |
Dr. Reddys Laboratories Louisiana LLC | Dr. Reddy's Laboratories | Louisiana | state | 2016 | $231,313 | | property tax abatement |
Dr. Reddys Laboratories Louisiana LLC | Dr. Reddy's Laboratories | Louisiana | state | 2016 | $868,373 | | property tax abatement |
ALERE SCARBOROUGH, INC. | Abbott Laboratories | Maine | state | 2016 | $8,387 | | property tax abatement |
IDEXX PHARMACEUTICALS INC | IDEXX Laboratories | Maine | state | 2016 | $3,600 | | property tax abatement |
IDEXX LAB INC | IDEXX Laboratories | Maine | state | 2016 | $30,147 | | property tax abatement |
IDEXX OPERATIONS INC | IDEXX Laboratories | Maine | state | 2016 | $41,242 | | property tax abatement |
Amgen USA, Inc. | Amgen | North Carolina | state | 2015 | $1,362 | | tax credit/rebate |
CNS Therapeutics, Inc. | Mallinckrodt | North Carolina | state | 2015 | $2,115 | | tax credit/rebate |
Lung Biotechnology, Inc. | United Therapeutics | North Carolina | state | 2016 | $2,270 | | tax credit/rebate |
Sprout Pharmaceuticals, Inc. | Bausch Health | North Carolina | state | 2016 | $2,940 | | tax credit/rebate |
Wyeth Pharmaceuticals, Inc. | Pfizer | North Carolina | state | 2016 | $3,214 | | tax credit/rebate |
Sprout Pharmaceuticals, Inc. | Bausch Health | North Carolina | state | 2015 | $3,313 | | tax credit/rebate |
Wyeth Pharmaceuticals, Inc. | Pfizer | North Carolina | state | 2015 | $3,442 | | tax credit/rebate |
Aerie Pharmaceuticals, Inc. | Aerie Pharmaceuticals | North Carolina | state | 2015 | $3,448 | | tax credit/rebate |
Forest Research Institute, Inc. | AbbVie | North Carolina | state | 2015 | $3,513 | | tax credit/rebate |
King Pharmaceuticals Research and Development, Inc. | Pfizer | North Carolina | state | 2016 | $3,809 | | tax credit/rebate |